Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

被引：0
|
作者：
Sharvina Ziyeh
Lauren Wong
Reva K. Basho
机构：
[1] UCLA Olive View Medical Center,
[2] Cedars-Sinai Medical Center,undefined
[3] The Lawrence J. Ellison Institute for Transformative Medicine,undefined
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Hormone receptor-positive breast cancer; HER2 negative breast cancer; Endocrine therapy; CDK4/6 inhibition; PI3K inhibition; AKT inhibition; PIK3CA mutation; SERDs; SERMs; PROTACs; SERCAs; CERANs; SARMs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：689 / 698
页数：9
相关论文
共 50 条
  • [21] Delay Discounting and Adjuvant Endocrine Therapy Adherence in Hormone Receptor-Positive Breast Cancer
    Vaughn, Jennifer E.
    Ammerman, Chesley
    Lustberg, Maryam B.
    Bickel, Warren K.
    Stein, Jeffrey S.
    HEALTH PSYCHOLOGY, 2021, 40 (06) : 398 - 407
  • [22] Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer
    Kantor, Olga
    Wakeman, Melia
    Weiss, Anna
    Wong, Stephanie
    Laws, Alison
    Grossmith, Samantha
    Mittendorf, Elizabeth A.
    King, Tari A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1358 - 1367
  • [23] Beliefs and attitudes toward endocrine therapy in patients with hormone receptor-positive breast cancer
    Kim, Yonglan
    Min, Yul Ha
    Lee, Sae Byul
    HEALTH CARE FOR WOMEN INTERNATIONAL, 2021, 42 (7-9) : 1086 - 1097
  • [24] The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
    Yuan, Jie
    Yang, Li
    Li, Zhi
    Zhang, Hua
    Wang, Qun
    Huang, Jun
    Wang, Bei
    Mohan, Chakrabhavi Dhananjaya
    Sethi, Gautam
    Wang, Geng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men
    Venigalla, Sriram
    Carmona, Ruben
    Guttmann, David M.
    Jain, Varsha
    Freedman, Gary M.
    Clark, Amy S.
    Shabason, Jacob E.
    JAMA ONCOLOGY, 2018, 4 (10)
  • [26] Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer
    Chia, Stephen
    Gradishar, William
    BREAST, 2008, 17 : S16 - S21
  • [27] A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer
    Bastiaannet, Esther
    Charman, Jackie
    Johannesen, Tom Borge
    Schrodi, Simone
    Siesling, Sabine
    van Eycken, Liesbet
    Walsh, Paul M.
    Audisio, Riccardo A.
    Boelens, Petra G.
    Rubio, Isabel T.
    Jones, Nick
    Lewis, Jan
    van de Velde, Cornelis J. H.
    CLINICAL BREAST CANCER, 2018, 18 (04) : E613 - E619
  • [28] Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
    Wu, Yun
    Han, Yiqun
    Yu, Pei
    Ouyang, Quchang
    Yan, Min
    Wang, Xiaojia
    Hu, Xichun
    Jiang, Zefei
    Huang, Tao
    Tong, Zhongsheng
    Wang, Shusen
    Yin, Yongmei
    Li, Hui
    Yang, Runxiang
    Yang, Huawei
    Teng, Yuee
    Sun, Tao
    Cai, Li
    Li, Hongyuan
    Chen, Xi
    He, Jianjun
    Liu, Xinlan
    Yang, Shune
    Qiao, Youlin
    Fan, Jinhu
    Wang, Jiayu
    Xu, Binghe
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [29] Gut and Breast Microbiota as Endocrine Regulators of Hormone Receptor-positive Breast Cancer Risk and Therapy Response
    Arnone, Alana A.
    Cook, Katherine L.
    ENDOCRINOLOGY, 2022, 164 (01)
  • [30] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    Anishka D’Souza
    Darcy Spicer
    Janice Lu
    Journal of Hematology & Oncology, 11
12345